OCGN

OCGN

Ocugen Inc

Rev โ€”top 1%10Y
Hold

Ocugen develops gene and cell therapies, biologics, and vaccines, targeting ocular conditions like retinitis pigmentosa and diabetic macular edema. Its pipeline includes novel treatments for genetic eye diseases and COVID-19 vaccines.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago โ†’$11today

Score Overview

1 Year
Score
Net Growth-20.58%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth3.78%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score4.8
Net Growth-40.17%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth199x
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-404.76%
Net Trend30%
Net Income Consistency
Rev Growthโ€”
Rev Trend60%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-258.93%
Net Trend33%
Net Income Consistency
Rev Growthโ€”
Rev Trend60%
Revenue Consistency

See the full market ranking โ†’

Ocugen Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 43K to $ 4M and net income went from -$ 21M to -$ 67M. Revenue increased in 4 of those 5 years; net income in 2.

Ocugen Inc currently holds a 5-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.40โ€”
1 Year2025-08-12
$ 1.0335.92%
5 Years2021-08-12
$ 7.97-82.43%
10 Years2016-08-12
$ 127.20-98.90%
All Time2014-12-03
$ 705.00-99.80%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 4M-$ 81M$ 100M
2025$ 4M-$ 67M$ 18M
2024$ 4M-$ 54M$ 58M
2023$ 6M-$ 63M$ 39M
2022$ 2M-$ 77M$ 90M
2021$ 22.92K-$ 58M$ 94M
2020$ 43K-$ 21M$ 24M
2019$ 42.62K-$ 20M$ 7M
2018$ 0.00-$ 8M$ 15M
2017$ 0.00-$ 26M$ 7M
2016$ 0.00-$ 16M$ 31M
2015-$ 32M$ 30M
IPO2014-$ 22M$ 58M

Explore beyond OCGN

You're looking at Ocugen Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies